BioNexus Gene Lab Corp

BGLC • NASDAQ

BioNexus Gene Lab Corp is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Su-Leng Tan, with a market cap of $4.7M.

CEOSu-Leng Tan

Market Cap$4.7M

Medical - Diagnostics & Research

Healthcare

Employees30.0

Websitebionexusgenelab.com

Country

United States of America

Next Earnings

Upcoming earnings announcement for BioNexus Gene Lab Corp

Date

Tuesday, April 14, 2026 (in 2 months)

Timing

Before Market Open (7:00 AM New York)

Fiscal Period

Q4 2025

Earnings History

Past 6 earnings reports for BioNexus Gene Lab Corp

Date	Period	EPS	EPS Surprise	Revenue	Rev. Surprise	Filing
Nov 14, 2025	Q3 2025	-$0.40	—	$2.5M	—	10-Q
Aug 18, 2025	Q2 2025	-$0.34	—	$2.3M	—	10-Q
Apr 15, 2025	Q4 2024	-$0.07	—	$2.5M	—	10-K/A
Nov 15, 2024	Q3 2024	-$0.02	—	$2.6M	—	10-Q
Aug 14, 2024	Q2 2024	$0.01	—	$2.0M	—	10-Q
May 15, 2024	Q1 2024	-$0.02	—	$2.4M	—	10-Q/A

View all filings on SEC EDGAR

BioNexus Gene Lab Corp

Next Earnings

Earnings History

Cookie Preferences